BOD Australia Ltd.
BOD Australia Ltd. (ASX:BDA) is a developer, distributor, and marketer of health and skincare products. Bod
works with plant-based extracts, with specific expertise in leveraging the health benefits associated with
cannabis and hemp. BOD is rapidly building an integrated cannabis business, underpinned by agreements with international counterparties Linnea SA, a leading Swiss botanicals extracts manufacturer and iX Biopharma Limited, a late-stage Singapore-listed pharmaceutical company. Bod is actively developing a range of over-the-counter and prescription products based on its unique, standardized, pharmaceutical grade cannabis extracts.
BOD Australia Ltd. has a large distribution footprint in Australia, selling prescription and OTC products to over 1,000 retail outlets, including pharmacies, retail stores, and healthcare chains. BOD Australia Ltd. also has distribution agreements with two of Australia’s largest pharmacy wholesalers providing it with access to over two thirds of the market. Bod is also actively building capability in key European markets that it witnesses near term growth prospects.